Study subjects who met the eligibility criteria and underwent examination by Cirrus HD-OCT were enrolled from a database of Japanese patients who were examined for glaucoma between April 17, 2008 and September 25, 2011, at the Department of Ophthalmology, Kyoto University Hospital. If both eyes of a subject were eligible for the study, one eye was chosen randomly for inclusion. Data for candidate control eyes were retrospectively collected from our database of Japanese normal volunteers who were determined by our department to have at least one healthy eye and who agreed to undergo the examinations described in this study.
All patients underwent a comprehensive ophthalmic examination that included measurement of uncorrected and best-corrected visual acuity using the 5-meter Landolt chart, slit-lamp examinations, intraocular pressure (IOP) measurements using a Goldman applanation tonometer, gonioscopy, dilated stereoscopic examination of the optic nerve head (ONH), stereo disc photography with a 3-Dx simultaneous stereo disc camera (Nidek; Gamagori, Japan), red-free fundus imaging using angiograph equipment (Heidelberg Retina Angiogram II [HRA2]; Heidelberg Engineering, Heidelberg, Germany); standard automated perimetry (SAP) using a visual field analyzer (Humphrey Visual Field Analyzer; Carl Zeiss Meditec, Inc.); and SD-OCT examination with OCT equipment (Carl Zeiss Meditec, Inc.).
All investigations in this study adhered to the tenets of the Declaration of Helsinki and the study was approved by the Institutional Review Board and Ethics Committee of Kyoto University Graduate School of Medicine. Informed consent was obtained from all participants.
For inclusion, subjects were required to have a best-corrected visual acuity of 20/20 or better in the Snellen equivalent, a spherical equivalent refractive error >−6 diopters (D) and <3 D, a normal open anterior chamber angle, macular cube scans (Carl Zeiss Meditec, Inc.) of good quality, and reliable visual field tests. Exclusion criteria were evidence of media opacities, such as corneal opacity, cataract, and vitreous opacity, vitreoretinal disease, uveitis, or nonglaucomatous optic neuropathy, or a history of intraocular surgery. Patients with neurological and systemic diseases that could affect retina and visual field results—such as cerebral infarction, cerebral tumor, uncontrolled hypertension, and blood disorders—were also excluded.
Glaucomatous eyes were defined by the presence of evident diffuse or localized rim thinning on stereo disc photography regardless of the presence (perimetric glaucoma)/absence (preperimetric glaucoma) of glaucomatous visual field defects or the presence of RNFL defects associated with glaucomatous visual field defects. Healthy subjects were enrolled by advertisement. Healthy controls had an IOP ≤21 mm Hg with no history of increased IOP, an absence of glaucomatous optic disc appearance on stereo disc photography, no RNFL defects on red-free fundus imaging, normal visual field testing results, and no family history of glaucoma.
Eyes were diagnosed as normal-tension glaucoma when all known untreated IOPs were ≤21 mm Hg, and otherwise as high-tension glaucoma.
Eyes with a mean deviation (MD) ≥−6 dB or <−6 dB were classified as early glaucoma or advanced glaucoma, respectively, based on the MD grouping of the Hodapp-Parrish-Anderson grading scale of severity of visual field defects.
22
The appearance of the optic disc on fundus photographs, including stereoscopic photographs, was evaluated by three glaucoma specialists (MH, HOI, and AN) who were masked to all other information about the eyes. If all three examiners did not agree on the classification, the eye was not used for analysis.